Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
83.19 EUR | +0.59% |
|
-0.16% | -11.25% |
09:48am | Thermo Fisher acquires Sanofi's New Jersey manufacturing site | RE |
09:45am | Thermo Fisher acquires Sanofi's New Jersey manufacturing site | RE |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 98,877 | 111,194 | 112,665 | 112,549 | 116,968 | 100,747 | - | - |
Change | - | 12.46% | 1.32% | -0.1% | 3.93% | -13.87% | - | - |
Enterprise Value (EV) 1 | 107,666 | 121,177 | 119,102 | 120,342 | 125,740 | 110,816 | 103,826 | 100,062 |
Change | - | 12.55% | -1.71% | 1.04% | 4.49% | -11.87% | -6.31% | -3.63% |
P/E ratio | 8.01x | 17.8x | 16.7x | 20.8x | 20.4x | 11.4x | 11.5x | 10.2x |
PBR | 1.57x | 1.62x | 1.5x | 1.52x | 1.51x | 1.29x | 1.23x | 1.17x |
PEG | - | -0.4x | 2.07x | -1.1x | 3.14x | 0.2x | -33.11x | 0.8x |
Capitalization / Revenue | 2.74x | 2.94x | 2.62x | 2.61x | 2.85x | 2.23x | 2.08x | 1.98x |
EV / Revenue | 2.99x | 3.21x | 2.77x | 2.79x | 3.06x | 2.45x | 2.15x | 1.96x |
EV / EBITDA | 9.41x | 9.95x | 8.14x | 8.44x | 9.76x | 8.01x | 7.03x | 6.43x |
EV / EBIT | 11x | 11.3x | 9.13x | 9.5x | 11.1x | 8.74x | 7.6x | 6.96x |
EV / FCF | 15.4x | 15x | 14x | 14.2x | 21.1x | 18.4x | 11.6x | 10.6x |
FCF Yield | 6.48% | 6.68% | 7.12% | 7.04% | 4.74% | 5.44% | 8.6% | 9.47% |
Dividend per Share 2 | 3.2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.066 | 4.257 | 4.471 |
Rate of return | 4.07% | 3.76% | 3.96% | 4.19% | 4.18% | 4.92% | 5.15% | 5.41% |
EPS 2 | 9.82 | 4.97 | 5.37 | 4.31 | 4.59 | 7.233 | 7.208 | 8.138 |
Distribution rate | 32.6% | 67% | 66.3% | 87.2% | 85.4% | 56.2% | 59.1% | 54.9% |
Net sales 1 | 36,041 | 37,761 | 42,997 | 43,070 | 41,081 | 45,168 | 48,389 | 50,984 |
EBITDA 1 | 11,443 | 12,183 | 14,627 | 14,259 | 12,889 | 13,832 | 14,779 | 15,570 |
EBIT 1 | 9,762 | 10,714 | 13,040 | 12,670 | 11,343 | 12,677 | 13,664 | 14,380 |
Net income 1 | 12,314 | 6,223 | 6,720 | 5,400 | 5,744 | 9,307 | 8,987 | 9,798 |
Net Debt 1 | 8,789 | 9,983 | 6,437 | 7,793 | 8,772 | 10,068 | 3,079 | -685.4 |
Reference price 2 | 78.70 | 88.58 | 89.84 | 89.76 | 93.74 | 82.70 | 82.70 | 82.70 |
Nbr of stocks (in thousands) | 1,256,375 | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,218,225 | - | - |
Announcement Date | 2/5/21 | 2/4/22 | 2/3/23 | 2/1/24 | 1/30/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
---|---|---|---|---|---|---|
11.43x | 2.45x | 8.01x | 4.92% | 117B | ||
36.3x | 11.99x | 27.31x | 0.77% | 693B | ||
14.87x | 4.16x | 11.44x | 3.38% | 373B | ||
26.58x | 6.4x | 13.41x | 3.51% | 329B | ||
16.64x | 6.03x | 12.06x | 3.05% | 299B | ||
14.05x | 3.47x | 8.57x | 3.87% | 255B | ||
17.27x | 4.6x | 11.14x | 3.3% | 235B | ||
22.12x | 4.13x | 12.16x | 2.29% | 218B | ||
10.44x | 3.39x | 7.33x | 3.95% | 205B | ||
22.37x | 5.73x | 11.06x | 3.28% | 157B | ||
Average | 19.21x | 5.24x | 12.25x | 3.23% | 288.15B | |
Weighted average by Cap. | 22.17x | 6.43x | 14.87x | 2.78% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions